Sex differences in the relationship between DHEAS and health

Experimental Gerontology

Volumn 42, Issue 10, 2007, Pages 979-987

  Goldman, Noreen ^a   Glei, Dana A ^b  

^a PRINCETON UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aged; Dehydroepiandrosterone; Dehydroepiandrosterone sulfate; Health; Longitudinal survey; Mental health; Taiwan

Indexed keywords

PRASTERONE SULFATE;

ADULT; AGED; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; HEALTH STATUS; HEALTH SURVEY; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REGRESSION ANALYSIS; SELF CONCEPT; SEX DIFFERENCE; TAIWAN;

AGED; AGING; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; COGNITION DISORDERS; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; DEPRESSION; FEMALE; GERIATRIC ASSESSMENT; HEALTH STATUS; HEALTH STATUS INDICATORS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PHYSICAL FITNESS; SEX CHARACTERISTICS; TAIWAN;

EID: 34548687433     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2007.05.005     Document Type: Article

References (41)

1. Barrett-Connor E., and Goodman-Gruen D. The epidemiology of DHEAS and cardiovascular disease. Ann. N.Y. Acad. Sci. 774 (1995) 259-270
2. Barrett-Connor E., Khaw K.T., and Yen S.S. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N. Engl. J. Med. 315 (1986) 1519-1524
3. Berr C., Lafont S., Debuire B., Dartigues J.F., and Baulieu E.E. Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study. Proc. Natl. Acad. Sci. USA 93 (1996) 13410-13415
4. Birkenhager-Gillesse E.G., Derksen J., and Lagaay A.M. Dehydroepiandrosterone sulphate (DHEAS) in the oldest old, aged 85 and over. Ann. N.Y. Acad. Sci. 719 (1994) 543-552
5. Boey K.W. Cross-validation of a short form of the CES-D in Chinese elderly. Int. J. Geriatr. Psychiatry 14 (1999) 608-617
6. Bovenberg S.A., van Uum S.H., and Hermus A.R. Dehydroepiandrosterone administration in humans: evidence based?. Neth. J. Med. 63 (2005) 300-304
7. Butcher S.K., and Lord J.M. Stress responses and innate immunity: aging as a contributory factor. Aging Cell. 3 (2004) 151-160
8. Cappola A.R., Xue Q.L., Walston J.D., Leng S.X., Ferrucci L., Guralnik J., and Fried L.P. DHEAS levels and mortality in disabled older women: the Women's Health and Aging Study I. J. Gerontol. A Biol. Sci. Med. Sci. 61 (2006) 957-962
9. Carlson L.E., Sherwin B.B., and Chertkow H.M. Relationships between dehydroepiandrosterone sulfate (DHEAS) and cortisol (CRT) plasma levels and everyday memory in Alzheimer's disease patients compared to healthy controls. Horm. Behav. 35 (1999) 254-263
10. Celec P., and Starka L. Dehydroepiandrosterone - is the fountain of youth drying out?. Physiol. Res. 52 (2003) 397-407
11. Dhatariya K., Bigelow M.L., and Nair K.S. Effect of dehydroepiandrosterone replacement on insulin sensitivity and lipids in hypoadrenal women. Diabetes 54 (2005) 765-769
12. Dudley R.A., Edwards P., Ekins R.P., Finney D.J., McKenzie I.G., Raab G.M., Rodbard D., and Rodgers R.P. Guidelines for immunoassay data processing. Clin. Chem. 31 (1985) 1264-1271
13. Feldman H.A., Johannes C.B., Araujo A.B., Mohr B.A., Longcope C., and McKinlay J.B. Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: prospective results from the Massachusetts Male Aging Study. Am. J. Epidemiol. 153 (2001) 79-89
14. Folan M.M., Stone R.A., Pittenger A.L., Stoffel J.A., Hess M.M., and Kroboth P.D. Dehydroepiandrosterone, dehydroepiandrosterone-sulfate, and cortisol concentrations in intensive care unit patients. Crit. Care Med. 29 (2001) 965-970
15. Glei D.A., Goldman N., Weinstein M., and Liu I.W. Dehydroepiandrosterone sulfate (DHEAS) and health: does the relationship differ by sex?. Exp. Gerontol. 39 (2004) 321-331
16. Goldman, N., Weinstein, M., Chang, M.C., Lin, H.S., Chuang, Y.L., Lin, Y.H., Lin, S.H., Liu I.W., Liu, H.Y., 2003a. 2000 Social Environment and Biomarkers of Aging Study in Taiwan (SEBAS): Main documentation for SEBAS public use data. Ann Arbor, MI: ICPSR.
17. Goldman N., Lin I.F., Weinstein M., and Lin Y.H. Evaluating the quality of self-reports of hypertension and diabetes. J. Clin. Epidemiol. 56 (2003) 148-154
18. Herbert J. The age of dehydroepiandrosterone. Lancet 345 (1995) 1193-1194
19. Kalmijn S., Launer L.J., Stolk R.P., de Jong F.H., Pols H.A., Hofman A., Breteler M.M., and Lamberts S.W. A prospective study on cortisol, dehydroepiandrosterone sulfate, and cognitive function in the elderly. J. Clin. Endocrinol. Metab. 83 (1998) 3487-3492
20. Khaw K.T. Dehydroepiandrosterone, dehydroepiandrosterone sulphate and cardiovascular disease. J. Endocrinol. Suppl. (1996) S149-S153
21. Kiechl S., Willeit J., Bonora E., Schwarz S., and Xu Q. No association between dehydroepiandrosterone sulfate and development of atherosclerosis in a prospective population study (Bruneck Study). Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1094-1100
22. Kroboth P.D., Amico J.A., Stone R.A., Folan M., Frye R.F., Kroboth F.J., Bigos K.L., Fabian T.J., Linares A.M., Pollock B.G., and Hakala C. Influence of DHEA administration on 24-h cortisol concentrations. J. Clin. Psychopharmacol. 23 (2003) 96-99
23. Kroboth P.D., Salek F.S., Pittenger A.L., Fabian T.J., and Frye R.F. DHEA and DHEA-S: a review. J. Clin. Pharmacol. 39 (1999) 327-348
24. Krstulovic A.M. Investigations of catecholamine metabolism using high-performance liquid chromatography: analytical methodology and clinical applications. J. Chromatogr. 229 (1982) 1-34
25. Labrie F., Luu-The V., Belanger A., Lin S.X., Simard J., Pelletier G., and Labrie C. Is dehydroepiandrosterone a hormone?. J. Endocrinol. 187 (2005) 169-196
26. Lezak M.D. Neuropsychological Assessment. second ed. (1983), Oxford University Press, New York
27. Long J.S., and Freese J. Regression Models for Categorical Dependent Variables using Stata (2006), Stata Press, College Station, TX
28. Mazat L., Lafont S., Berr C., Debuire B., Tessier J.F., Dartigues J.F., and Baulieu E.E. Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: relationship to gender, subjective health, smoking habits, and 10-year mortality. Proc. Natl. Acad. Sci. USA 98 (2001) 8145-8150
29. Nafziger A.N., Herrington D.M., and Bush T.L. Dehydroepiandrosterone and dehydroepiandrosterone sulfate: their relation to cardiovascular disease. Epidemiol. Rev. 13 (1991) 267-293
30. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J. Am. Geriatr. Soc. 23 (1975) 433-441
31. Porsova-Dutoit I., Sulcova J., and Starka L. Do DHEA/DHEAS play a protective role in coronary heart disease?. Physiol. Res. 49 Suppl. 2 (2000) S43-S56
32. Ravaglia G., Forti P., Maioli F., Boschi F., Bernardi M., Pratelli L., Pizzoferrato A., and Gasbarrini G. The relationship of dehydroepiandrosterone sulfate (DHEAS) to endocrine-metabolic parameters and functional status in the oldest-old. results from an Italian study on healthy free-living over-ninety-year-olds. J. Clin. Endocrinol. Metab. 81 (1996) 1173-1178
33. Ravaglia G., Forti P., Maioli F., Sacchetti L., Nativio V., Scali C.R., Mariani E., Zanardi V., Stefanini A., and Macini P.L. Dehydroepiandrosterone-sulfate serum levels and common age-related diseases: results from a cross-sectional Italian study of a general elderly population. Exp. Gerontol. 37 (2002) 701-712
34. Roth G.S., Lane M.A., Ingram D.K., Mattison J.A., Elahi D., Tobin J.D., Muller D., and Metter E.J. Biomarkers of caloric restriction may predict longevity in humans. Science 297 (2002) 811
35. StataCorp, 2005. Stata User's Guide: Release 9.0. Stata Corporation, College Station, TX.
36. Thijs L., Fagard R., Forette F., Nawrot T., and Staessen J.A. Are low dehydroepiandrosterone sulphate levels predictive for cardiovascular diseases? A review of prospective and retrospective studies. Acta Cardiol. 58 (2003) 403-410
37. Thijssen J.H.H., and Nieuwenhuyse H. DHEA: A Comprehensive Review (1999), Parthenon, Pearl River, NY
38. Tilvis R.S., Kahonen M., and Harkonen M. Dehydroepiandrosterone sulfate, diseases and mortality in a general aged population. Aging (Milano) 11 (1999) 30-34
39. Trivedi D.P., and Khaw K.T. Dehydroepiandrosterone sulfate and mortality in elderly men and women. J. Clin. Endocrinol. Metab. 86 (2001) 4171-4177
40. Wechsler D. WAIS-R Manual (1981), Psychological Corporation, New York
41. Yaffe K., Ettinger B., Pressman A., Seeley D., Whooley M., Schaefer C., and Cummings S. Neuropsychiatric function and dehydroepiandrosterone sulfate in elderly women: a prospective study. Biol. Psychiatry 43 (1998) 694-700